Phase 2 Readout~quarter

Phase 2 Readout: rese-cel

Indication
dermatomyositis/antisynthetase syndrome

Other upcoming events for CABA

Phase 2 ReadoutPhase 2 Readout: rese-cel
Phase 3 ReadoutPhase 3 Topline: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimer

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: rese-cel — CABA Phase 2 Readout | BioSniper